Cargando…

Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice

Angelman syndrome (AS) is a genetic neurodevelopmental disorder, most commonly caused by deletion or mutation of the maternal allele of the UBE3A gene, with behavioral phenotypes and seizures as key features. Currently no treatment is available, and therapeutics are often ineffective in controlling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Born, Heather A., Dao, An T., Levine, Amber T., Lee, Wai Ling, Mehta, Natasha M., Mehra, Shubhangi, Weeber, Edwin J., Anderson, Anne E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559514/ https://www.ncbi.nlm.nih.gov/pubmed/28814801 http://dx.doi.org/10.1038/s41598-017-08825-x

Ejemplares similares

Early Developmental EEG and Seizure Phenotypes in a Full Gene Deletion of Ubiquitin Protein Ligase E3A Rat Model of Angelman Syndrome
por: Born, Heather A., et al.
Publicado: (2021)

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model
por: Milazzo, Claudia, et al.
Publicado: (2021)

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

From UBE3A to Angelman syndrome: a substrate perspective
por: Sell, Gabrielle L., et al.
Publicado: (2015)

Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model
por: Filonova, Irina, et al.
Publicado: (2014)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
por: Sato, Masaaki
Publicado: (2017)

Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
por: Meng, Linyan, et al.
Publicado: (2013)

Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021)

Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2016)

Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice
por: Jones, Kelly A., et al.
Publicado: (2016)

The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
por: Khatri, Natasha, et al.
Publicado: (2019)

Corrigendum: Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2018)

Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila
por: Li, Wenhua, et al.
Publicado: (2016)

Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
por: Sell, Gabrielle L., et al.
Publicado: (2021)

The role of whole exome sequencing in the UBE3A point mutation of Angelman Syndrome: A case report
por: Triono, Agung, et al.
Publicado: (2021)

Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome
por: Spencer, Elizabeth R., et al.
Publicado: (2022)

Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial
por: Herber, Donna L., et al.
Publicado: (2020)

Genotype–Phenotype Correlations in Angelman Syndrome
por: Yang, Lili, et al.
Publicado: (2021)

A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
por: Geerts‐Haages, Amber, et al.
Publicado: (2020)

Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3
por: Jiang, Yong-hui, et al.
Publicado: (2010)

An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome
por: Grieco, Joseph C, et al.
Publicado: (2014)

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology
por: Pandya, Nikhil J., et al.
Publicado: (2021)

Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain
por: Bailus, Barbara J, et al.
Publicado: (2016)

Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome
por: Schultz, Maria N., et al.
Publicado: (2020)

Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the Ube3a Deletion Rat Model of Angelman Syndrome
por: Berg, Elizabeth L., et al.
Publicado: (2021)

Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
por: Syding, Linn Amanda, et al.
Publicado: (2022)

Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans
por: Landers, Miguel, et al.
Publicado: (2005)

Adeno-Associated Virus-Mediated Rescue of the Cognitive Defects in a Mouse Model for Angelman Syndrome
por: Daily, Jennifer L., et al.
Publicado: (2011)

Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome
por: Hethorn, Whitney R, et al.
Publicado: (2015)

Angelman Syndrome Protein UBE3A Interacts with Primary Microcephaly Protein ASPM, Localizes to Centrosomes and Regulates Chromosome Segregation
por: Singhmar, Pooja, et al.
Publicado: (2011)

Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome
por: Tomaić, V, et al.
Publicado: (2015)

PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome
por: Sun, Jiandong, et al.
Publicado: (2020)

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
por: Judson, Matthew C., et al.
Publicado: (2021)

1031-1034delTAAC (Leu125Stop): a novel familial UBE3A mutation causing Angelman syndrome in two siblings showing distinct phenotypes
por: De Molfetta, Greice Andreotti, et al.
Publicado: (2012)

Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature
por: Aguilera, Cinthia, et al.
Publicado: (2017)

Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome
por: Berg, Elizabeth L., et al.
Publicado: (2021)

Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome
por: Lee, Hyeong-Min, et al.
Publicado: (2018)

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
por: Sonzogni, Monica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a2i84qh8pu1fe6t2enjajsthp5